‘Pay For Delay’ Drug Accords Get U.S. High Court Scrutiny

in 2012, Bloomberg, Keith Hylton, Newsmakers, School of Law
December 7th, 2012

Keith Hylton, School of Law

The U.S. Supreme Court agreed to take up a multibillion-dollar fight between the drug industry and federal antitrust enforcers, a case that may determine how quickly low-price generic medicines reach the market…

View article

Comments are closed.